Dosage, Efficacy and Safety of Cannabidiol Administration in Adults: A Systematic Review of Human Trials

Posted on July 22, 2022

Considering data from in vitro and in vivo studies, cannabidiol (CBD) seems to be a promising candidate for the treatment of both somatic and psychiatric disorders. The aim of this review was to collect dose(s), dosage schemes, efficacy and safety reports of CBD use in adults from clinical studies. A systematic search was performed in PubMed, Embase and Cochrane library for articles published in English between January 1, 2000 and October 25, 2019. The search terms used were related to cannabis and CBD in adults. We identified 25 studies (927 patients; 538 men and 389 women), of which 22 studies were controlled clinical trials (833 patients) and three were observational designs (94 patients) from five countries

Cannabidiol primer for healthcare professionals

Posted on July 22, 2022

Emerging research and clinical data are demonstrating the potential benefits of cannabidiol for multiple medical conditions. This article gives healthcare providers information on cannabidiol and the endocannabinoid system as a foundation on which to build their medical knowledge as the risks and benefits of CBD in various diseases are further evaluated over time.

Cannabidiol (CBD) [Continuing Education]

Posted on July 1, 2022


  • Review the current and future indications for CBD.
  • Explain the importance of monitoring patients on CBD.
  • Summarize the contraindications and factors to consider when prescribing CBD.
  • Describe the importance of collaboration and communication amongst the interprofessional team to improve outcomes for patients receiving CBD.

1 credit [MD/PA, DO, AANP/NP, ACPE/Pharmacist]